doi.org/10.1016/s1474-4422(22)00082-5

Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

..., John Collinge
78
The Lancet Neurology45.50
Volume: 21, Issue: 4, Pages: 342 - 354
Published: Mar 16, 2022
Paper Fields
Paper Details
Title
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
DOI
doi.org/10.1016/s1474-4422(22)00082-5
Published Date
Mar 16, 2022
Journal
The Lancet Neurology
Volume
21
Issue
4
Pages
342 - 354
© 2025 Pluto Labs All rights reserved.